RiboMed is a molecular diagnostic company providing genetic and epigenetic biomarker tests for Personalized Medicine. RiboMed uses its proprietary and patented technologies for methylated DNA isolation and quantification (MethylMagnet and MethylMeter) and biomarker detection (Abscription).
SeqWright is a Contract Research Organization (CRO) specialized in providing a variety of genomic services, including molecular biology, nucleic acid technology, microarray, next generation genomics, etc…
Covaris is a biotech company innovating in sample preparation thanks to its focused-ultrasonication technologies. This Covaris AFA process and its high level of experimental condition control enable high quality sample preparation for biotech and biopharma research.
CH3 BioSystems is a biotech company manufacturing novel molecular tools to help biomedical research better understand cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases thanks to a new patent-protected chemical technology.
eTherapeutics is a drug discovery and development company, applying network pharmacology to find new treatments for human disease. eTherapeutics has a very promising clinical pipeline and is also looking for new candidates.
Biogenex is a biotech company developing automated slide-based staining instruments and offering a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR, multiplex and special staining of tissues.
ChemoMetec is a biotech company aiming to improve analytical measurement techniques within the fields of particle counting and liquid chemical composition determination. ChemoMetec mainly focus in liquids analysis, especially for use in life sciences research, clinical diagnostics, production and quality control for pharmaceutical industries.
Viralytics is a biotech company focusing on the development of oncolytic immunotherapies, using the specific property of certain viruses to preferentially infect and kill cancer cells. Viralytics’ lead product candidate is CAVATAK, a proprietary formulation of the common Coxsackievirus Type A21 (CVA21), evaluated in Phase 1 and 2 clinical trials.
eBioscience is a biotech company providing high quality reagents that empower the process of scientific discovery in cellular immunity and oncology, mainly focusing in flow cytometry and immunodetection.
Axela offers a unique portfolio of next generation multiplex tools for enhanced analysis of proteins, RNA and DNA. Axela’s products include instruments, consumable (chips, sensors and reagents) and applications (biomarker content, methods for analysis and software) and are widely used for biomarker testing and infectious disease research.
